A pharmaceutical company stands accused of putting profit before patients after withdrawing a drug used in the treatment of a chronic debilitating disease – ahead of relaunching it at a price predicted to be up to 20 times higher.
Exclusive: MS drug 'rebranded' – at up to 20 times the price
Current Status: Published (4)
Seeded by Michael Sautter View Original Article: 
Independent.co.uk
Seeded on Fri Oct 12, 2012 4:41 PM
keyboard shortcuts: V vote up article J next comment K previous comment